Nobel Laureate Dr. Ferid
at Houston, Medical School
Nitric Oxide to Viagra - The Innovation Continues.....read
Nobel Laureate Dr. Eric
Harvard Medical School
Health to Global Environment & Nature......read
The Biotech & Life
Sciences Global Venture Congress™ conference is designed to
explore the frontiers of biotech & life sciences, address the
venture capital landscape, and discover cutting-edge Biotech and
Life Sciences companies. A “one-of-a-kind
conference” meant for those great minds, visionaries
& entrepreneurs who want to do someting different, something
Two Nobel Laureate plenary sessions, six (6) panel
discussions, 25+ Distinguished Speakers, two(2) innovative company
presentation sessions, exclusive networking breaks, excellent
menu, premium wine/beer selections, and a private VIP cocktail
President/CEO - Digital Bio (South Korea);
CEO - Med Discovery (Switzerland); Director - Exgenis
(UK); CEO - Congenix (Russia); Managing Director-
The Carlyle Group; Professor Of Medicine- Columbia
University; Partner - Phillips Nizer, LLP; Biotech
Executive - Microsoft; President & CEO- Serenex,
Inc.; President & CEO- BioTrove; President &
COO- Pharmos Corporation; Principal- The Aurora Funds;
Principal- Cannon Design; Principal- Bear Stearns
Health Innoventures; Biotech Entrepreneur (M.D., Ph.D) -
Harvard Medical School; Tech. Advisor & Patent Agent-
Stroock & Stroock & Lavan; Sr. Vice President-
Life Sciences Greenhouse; Sr. Vice President- William
Gallagher Associates; VP of Research & Development/ CSO-
Locus Pharmaceuticals, Inc; VP, Business Development-
Chugai Pharma USA; Vice President- Cytel Inc.; and
Drug discovery and drug development company with drugs in
Pre-clinical trials and Phase II.. So far it has raised
over $25 million and is seeking $30 million in Series C
- Computational drug design
and drug development company expected to file 3 INDs within
the next year. Has raised $87.8 million and is currently
seeking an additional $25 million.
Company C - Company developing
topical products for viral, fungal, and bacterial infections.
Have completed several Phase I and Phase II trials. So far
has raised $2.6 million and is currently seeking $15 million.
to see details and apply now.
Speakers at the conference are world renowned visionaries,
carefully chosen active investors in Biotech and Life Sciences companies,
founders/C-level executives of cutting edge Biotech companies and
renowned thought leaders, movers and shakers of the biotech industry
and analysts. More than 25 speakers already confirmed. Click here
to see confirmed speakers.
"Honesty, Integrity, Leadership, and Philanthropy"
(L) Nobel Laureate Dr. Ferid Murad
(R) Dr. Gyan Parida, Chairman
BioCongress, Aug 25, 2005, New York
(L) Nobel Laureate Dr. Eric Chivian
(R) Dr. Gyan Parida, Chairman
BioCongress, Aug 26, 2005, New York
schedule, date, location and speakers are subject to change
Bio in .pdf
Bio in .doc
Elaine V. Jones, Ph.D.
Euclid SR Partners
A. Dana Callow, Jr.
Managing General Partner
Boston Millennia Partners
Muz Mansuri, Ph.D.
Frazier Healthcare Ventures
Managing Partner, Founder
Jesse I. Treu, Ph.D
Steven St. Peter, M.D.
SV Life Sciences Advisers